Hypothesizing that Putative Dopaminergic, Melatonin, Benzodiazepine Reward Circuitry Receptor(s) Activator Provides Sleep Induction Benefits

Kenneth Blum^1,3*, Marlene-Oscar-Berman², William Downs B³, Eric R Braverman^1,4, Florian Kreuk⁴, Kristina Dushaj⁴, Courtney Truesdell⁴, Mona Li⁴, John Giordano⁵, Joan Borsten⁶, Thomas Simpatico⁷, Debmayla Barh⁸, Margaret A Madigan^3,4,9, Scott Jones⁵ and Stephen Schoenthaler^5,10

¹Department of Psychiatry, University of Florida, McKnight Brain Institute, USA, E-mail: marlene_oscar@gmail.com

²omi_departments of Psychiatry and Anatomy and Neurobiology, Boston University School of Medicine, and Boston VA Healthcare System, Boston, USA, E-mail: marlene_oscar@gmail.com

³Impact genomics, Inc., Lederoch, Pennsylvania, USA, E-mail: marlene_oscar@gmail.com

⁴Department of Clinical Neurology, Path Research Foundation, USA, E-mail: marlene_oscar@gmail.com

⁵Department of Holistic Medicine, National Institute for Holistic Addiction Studies, USA, E-mail: marlene_oscar@gmail.com

⁶Department of Addiction Research and Therapy, Malibu Beach Recovery Center, USA, E-mail: marlene_oscar@gmail.com

⁷Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, USA, E-mail: marlene_oscar@gmail.com

⁸Institute of Integrative Omics & Applied Biotechnology, India, E-mail: marlene_oscar@gmail.com

⁹Department of Personalized Genomics, IGENE LLC., USA, E-mail: marlene_oscar@gmail.com

¹⁰Department of Sociology, California State University, USA, E-mail: marlene_oscar@gmail.com

^*Corresponding Author: Kenneth Blum, Department of Psychiatry, McKnight Brain Institute, Gainesville, Florida, USA, Tel: 619-890-2167 Email: